This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Teresa Sharav, MB, BS, MPH; Roger M. Collins, Jr; Peter J. Baab, MS

Am J Dis Child. 1988;142(12):1302-1306.

Abstract
• A retrospective survey of 147 patients with Down's syndrome (age range, 4 months to 27 years) showed that 60% had a thyrotropin (TSH) level higher than 5.7 mU/L in the presence of high or normal thyroxine levels. The remaining 40% of the group had low to normal TSH values. High TSH levels were predominant in patients under 4 years of age (94 children), ie, during the phase of active growth, and showed a declining trend with increasing age. All 94 infants had delayed growth of all parameters including head circumference, height, and weight, as compared with normal infants, and growth was particularly retarded in patients with TSH levels greater than 5.7 mU/L. Thyroid dysfunction, expressed as a high TSH concentration, is associated with growth retardation in children with Down's syndrome who are younger than 4 years.

(AJDC 1988;142:1302-1306)

Author Affiliations
From the Hadassah-WIZO-Canada Research Institute, Jerusalem (Dr Sharav), and Department of Pediatrics, W P. Carter Center School of Medicine, University of Maryland, Baltimore (Mssrs Collins and Baab).

Footnotes
Accepted for publication July 10, 1988.

Reprint requests to Hadassah-WIZO-Canada Research Institute, 6 Karmon St, Beit Hakerem, Jerusalem 96308, Israel (Dr Sharav).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Median Nerve Conduction Velocity and Central Conduction Time Measured With Somatosensory Evoked Potentials in Thyroxine-Treated Infants With Down Syndrome
van Trotsenburg et al.
Pediatrics 2006;118:e825-e832.
ABSTRACT | FULL TEXT  

The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial
van Trotsenburg et al.
J. Clin. Endocrinol. Metab. 2005;90:3304-3311.
ABSTRACT | FULL TEXT  

Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns
van Trotsenburg et al.
J. Clin. Endocrinol. Metab. 2003;88:1512-1515.
ABSTRACT | FULL TEXT  

New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland
Styles et al.
Arch. Dis. Child. 2002;87:104-108.
ABSTRACT | FULL TEXT  

Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson et al.
Arch. Dis. Child. 1998;79:242-245.
ABSTRACT | FULL TEXT